| Recruiting | Clinical Trials of Quadrivalent Influenza Vaccine Influenza, Human | Phase 1 / Phase 2 | 2025-05-08 |
| Recruiting | BCG for Therapeutic Use Phase Ⅲ Clinical Trial BCG | Phase 3 | 2025-04-08 |
| Active Not Recruiting | Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) Acute Gastroenteropathy Due to Norovirus | Phase 3 | 2024-07-27 |
| Completed | BCG for Therapeutic Use Phase I Clinical Trial Non-muscular Invasive Bladder Cancer | Phase 1 | 2023-11-22 |
| Unknown | Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells) Coronavirus | N/A | 2023-09-20 |
| Unknown | Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical Trial COVID-19 | Phase 1 | 2023-09-01 |
| Recruiting | Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above Latent Tuberculosis Infection | Phase 3 | 2023-08-03 |
| Completed | Phase II Clinical Clical of the Pure Protein Derivatives of BCG Tuberculosis | Phase 1 | 2023-07-26 |
| Active Not Recruiting | Clinical Trial of Mica Latent Tuberculosis Infection | Phase 4 | 2023-04-19 |
| Completed | Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein Latent Tuberculosis Infection | Phase 4 | 2023-04-17 |
| Completed | Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells) Coronavirus | N/A | 2023-03-17 |
| Completed | Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine Prevention of Influenza | Phase 3 | 2023-02-18 |
| Unknown | A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell COVID-19 | Phase 3 | 2022-11-07 |
| Completed | Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell) COVID-19 | N/A | 2022-08-29 |
| Completed | To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus COVID-19 | N/A | 2022-04-29 |
| Unknown | Safety Study of COVID19 Vaccine on the Market COVID-19 | Phase 4 | 2022-04-02 |
| Suspended | A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) Tuberculosis | Phase 2 | 2022-02-10 |
| Completed | ZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic Immunization Prevention of COVID-19 | Phase 1 / Phase 2 | 2022-01-10 |
| Completed | ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization Prevention of COVID-19 | Phase 1 / Phase 2 | 2021-12-29 |
| Unknown | Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorV COVID-19 | Phase 1 / Phase 2 | 2021-11-10 |
| Completed | Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac COVID-19 | Phase 1 / Phase 2 | 2021-11-10 |
| Completed | Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell) COVID-19 | Phase 2 | 2021-11-04 |
| Unknown | Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell) Coronavirus Disease 2019 | Phase 3 | 2021-09-17 |
| Unknown | Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Coronavirus Disease 2019 | Phase 3 | 2021-09-09 |
| Completed | Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine Coronavirus Disease 2019 | Phase 3 | 2021-09-03 |
| Completed | Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunit Coronavirus Disease 2019 | N/A | 2021-08-31 |
| Completed | Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Y Coronavirus | Phase 1 | 2021-07-03 |
| Active Not Recruiting | Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis Patients Tuberculosis | Phase 1 | 2021-07-02 |
| Unknown | A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells) Rabies Vaccine Adverse Reaction, Safety and Efficacy | Phase 3 | 2021-04-10 |
| Unknown | A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19 Prevention of COVID-19, Safety and Efficacy | Phase 3 | 2020-12-16 |
| Completed | Clinical Study of BCG Vaccine for Intradermal Injection Tuberculosis | Phase 1 | 2020-10-21 |
| Completed | Phase I Clinical Protocol of BCG-PPD in Healthy People Tuberculosis | Phase 1 | 2020-10-21 |
| Unknown | Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old) Coronavirus | Phase 1 | 2020-08-19 |
| Completed | Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) Acute Gastroenteritis | Phase 1 / Phase 2 | 2020-08-05 |
| Unknown | Clinical Study of Recombinant Novel Coronavirus Vaccine Coronavirus | Phase 2 | 2020-07-12 |
| Unknown | Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine Coronavirus | Phase 1 | 2020-06-22 |
| Completed | A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) Tuberculosis | Phase 1 | 2020-05-27 |
| Completed | A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells) Rabies Vaccine Adverse Reaction | Phase 3 | 2019-10-19 |
| Completed | A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried Tuberculosis | Phase 1 | 2018-04-16 |
| Completed | Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen for Children Tuberculosis Diagnosis | Phase 3 | 2016-10-01 |
| Completed | Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65(III Tuberculosis | Phase 3 | 2016-05-01 |
| Completed | Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen Tuberculosis | Phase 3 | 2015-12-01 |
| Completed | Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged Tuberculosis | Phase 2 | 2015-03-01 |
| Completed | Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 Tuberculosis | Phase 2 | 2014-11-01 |
| Completed | Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 Tuberculosis | Phase 2 | 2014-02-01 |
| Completed | Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis Tuberculosis | Phase 3 | 2013-10-01 |
| Completed | Phase I Clinical Human Tolerability Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 Healthy | Phase 1 | 2013-09-01 |